Immunomodulators (IL-6 pathway biologics)
- Block IL-6 receptor/signaling
- Tocilizumab/sarilumab are prototypes
- Uses include RA, GCA + cytokine release syndrome
- Infection, neutropenia + LFT effects matter
- Can raise lipids
- CRP may be suppressed despite serious infection
Class at a glance
- Block IL-6 receptor/signaling
Practical pearls
- Tocilizumab/sarilumab are prototypes
Clinical role
- Uses include RA, GCA + cytokine release syndrome
- Can raise lipids
Other clinical roles
- Infection, neutropenia + LFT effects matter
- CRP may be suppressed despite serious infection
Self-check
- What is the main pharmacologic action of Immunomodulators (IL-6 pathway biologics)?
Block IL-6 receptor/signaling.
Drugs in this class (3)
All drug classes · Open the interactive console ↗
